Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Evaluation of the Phantom X Implantable EMG Sensor System for Myoelectric Prosthesis Control

NCT: NCT07325708 · RECRUITING

NCT IDNCT07325708
StatusRECRUITING
Start Date2026-04-17
Completion2027-06
SponsorPhantom Neuro Inc. (INDUSTRY)
First posted
Last updated

Brief Summary

The CYBORG Study is a first-in-human clinical investigation evaluating the safety and performance of the Phantom X System, an implantable electromyography (EMG) sensor array designed to provide control of upper-limb prostheses. The study will assess surgical feasibility, device function, signal quality, and the system's ability to support intuitive prosthetic control during functional tasks. Participants will undergo implantation of the Phantom X sensors and complete a series of in-clinic visits to assess functional performance of the Phantom X system. Patient-reported outcomes will also be collected at various timepoints.

Frequently Asked Questions

What is Evaluation of the Phantom X Implantable EMG Sensor System for Myoelectric Prosthesis Control?

Evaluation of the Phantom X Implantable EMG Sensor System for Myoelectric Prosthesis Control is a clinical trial registered under NCT07325708. Current status: RECRUITING.

What is the status of NCT07325708?

The current status of NCT07325708 (Evaluation of the Phantom X Implantable EMG Sensor System for Myoelectric Prosthesis Control) is: RECRUITING.

When did Evaluation of the Phantom X Implantable EMG Sensor System for Myoelectric Prosthesis Control start?

Evaluation of the Phantom X Implantable EMG Sensor System for Myoelectric Prosthesis Control started on 2026-04-17.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.